Senior Vice President, Finance
Thu, Jun 11, 2026
Jun 11
6,115 shares @ $23.50
Decreased holdings by -8.90%
9th largest trade (out of 81)
Planned (10b5-1)Positive 90D History
“The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. The Rule 10b5-1 trading plan was adopted on March 12, 2026.”Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
63% win rate · +10.4% median edge vs SPY (8 trades, 90-day · small sample)
Small Cap stock — insider trades carry more weight
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
PCRXPacira BioSciences, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+5.09%
1M-5.51%
3M+4.33%
6M—
1Y—